Compare ROIV & DOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | DOV |
|---|---|---|
| Founded | 2014 | 1947 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 27.4B |
| IPO Year | 2021 | 1994 |
| Metric | ROIV | DOV |
|---|---|---|
| Price | $38.91 | $195.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | $50.82 | ★ $238.00 |
| AVG Volume (30 Days) | ★ 7.1M | 1.2M |
| Earning Date | 11-09-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 1.05% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 6.53 |
| Revenue | $8,260,000.00 | ★ $6,992,118,000.00 |
| Revenue This Year | $1,870.25 | $7.60 |
| Revenue Next Year | $271.46 | $5.76 |
| P/E Ratio | ★ N/A | $30.62 |
| Revenue Growth | N/A | ★ 2.51 |
| 52 Week Low | $19.96 | $181.66 |
| 52 Week High | $42.50 | $237.54 |
| Indicator | ROIV | DOV |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 38.19 |
| Support Level | $33.11 | $192.65 |
| Resistance Level | $42.37 | $217.44 |
| Average True Range (ATR) | 1.55 | 5.72 |
| MACD | -0.07 | -2.07 |
| Stochastic Oscillator | 49.40 | 3.72 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.